Rekindling the Doctor, Patient Relationship

At the end of the day, when patients and doctors are unable to effectively engage in health care conversations, the quality of care and patient health suffer, resulting in rising U.S. healthcare costs, lower quality of care, and unhealthy patients.  The post Rekindling the Doctor, Patient Relationship appeared first on MedCity News.

Read More

Beyond the Hype: The Scientific and Commercial Future of Microbiome Medicine

By aligning innovative scientific insights with strategic commercial pathways, the industry has the potential to fulfill its early promise – delivering safe, effective therapies that improve patient outcomes and create new opportunities for growth in the biopharmaceutical sector. The post Beyond the Hype: The Scientific and Commercial Future of Microbiome Medicine appeared first on MedCity…

Read More

How AI Is Paying Off: 5 Wins at Advocate Health

Andy Crowder, chief digital officer at Advocate Health, detailed five benefits his health system is experiencing as a result of being bullish on AI — including better staff retention, clinical improvements and cost savings. The post How AI Is Paying Off: 5 Wins at Advocate Health appeared first on MedCity News.

Read More

Immunology Startup Merida Bio Unveils $121M and a Lead Program for Graves’ Disease

Merida Biosciences is developing antibody-like drugs designed to selectively eliminate disease-driving autoantibodies while sparing healthy components of the immune system. Graves disease, which stems from the immune system’s attack on the thyroid gland, is the startup’s lead disease target. The post Immunology Startup Merida Bio Unveils $121M and a Lead Program for Graves’ Disease appeared…

Read More